bladder cancer
Diatech, Janssen Partner to Develop Molecular Diagnostics for Bladder Cancer
The bladder cancer test in development will profile genetic alterations in bladder cancer in three hours using real-time PCR.
Convergent Genomics Building Data on Urine-Based Assay to Diagnose, Monitor Urothelial Carcinoma
Premium
The Oregon Health and Science University spinout also recently presented data suggesting the test could help predict future urothelial carcinoma.
Nucleix Bladder EpiCheck Cancer Liquid Biopsy Test Gets FDA 510(k) Clearance
The DNA methylation-based urine PCR test is cleared for monitoring patients diagnosed with non-muscle invasive bladder cancer for recurrence.
Pacific Edge Ramps up Clinical Utility Studies, Commercial Efforts Behind Bladder Cancer Test
Premium
The New Zealand-based diagnostics firm is hoping the coming year will be a tipping point toward new guideline inclusion and broader adoption.
The company's next-generation sequencing-based test detects more than 400 recurrent alterations that can identify 96 percent of bladder cancers.
Feb 15, 2023
Jun 17, 2022
Nonagen Gets CE Mark for Bladder Cancer Immunoassay
Jun 15, 2022
Paige, Janssen Partner on Bladder Cancer Dx
Jan 20, 2022